Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Ra Capital Management, L.P. bought 32,876 Artiva Biotherapeutics, Inc. shares (Form 4)
Traded Jun 25 to Jun 26, 2026 · Filed Jun 29, 2026
From Jun 25 to Jun 26, 2026, Ra Capital Management, L.P. (Director, 10% owner) bought 32,876 Artiva Biotherapeutics, Inc. shares at an average US$8.89 for US$292K, leaving 16,795,919 shares. Filed Jun 29, 2026 (Form 4).
- Bought
- 32,876 shares
- Price
- US$8.89 average (US$8.88 to US$8.98)
- Value
- US$292K
- Holding after
- 16,795,919 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | Common Stock | Buy | 31,000 | US$8.88 | 16,794,043 | Indirect |
| Jun 26, 2026 | Common Stock | Buy | 1,876 | US$8.98 | 16,795,919 | Indirect |